PROCTER & GAMBLE Co (PG) operating KPIs

PGNYSESoap, Detergents, Cleang Preparations, Perfumes, CosmeticsFiscal year ends June 30

Financials through Q4 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Oct 22, 2026Score 12/306% above fair value

$161.57+0.98 (+0.61%)

Close on Oct 30, 2026Market cap $375.56BP/E 24.4Yield 2.64%

Procter & Gamble health Care — Net Sales ($M)

Form 10-Q & Form 10-K Note 2 (Segment Reporting)

Quarterly Annual

Latest, Q1 FY27

3,318

Period ended Sep 30, 2026

Change on a year earlier

+3.0%

3,220 in Q1 FY26

History

65 quarters

Since Q3 FY10

Sources

Documents cited below

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

Period	Ended	Health Care — Net Sales ($M)	Year on year	Source
Q1 FY27	Sep 30, 2026	3,318	+3.0%	Form 10-Q (FY2027Q1), filed 2026-10-22 ↗
Q4 FY26	Jun 30, 2026	2,757	+1.3%	Form 10-K, filed 2026-08-04 ↗
Q3 FY26	Mar 31, 2026	3,073	+6.7%	Form 10-Q (FY2026Q3), filed 2026-04-24 ↗
Q2 FY26	Dec 31, 2025	3,406	+4.8%	Form 10-Q (FY2026Q2), filed 2026-01-23 ↗
Q1 FY26	Sep 30, 2025	3,220	+2.3%	Form 10-Q (FY2027Q1), filed 2026-10-22 ↗
Q4 FY25	Jun 30, 2025	2,721	+1.8%	Form 10-K, filed 2025-08-04 ↗
Q3 FY25	Mar 31, 2025	2,880	+0.2%	Form 10-Q (FY2026Q3), filed 2026-04-24 ↗
Q2 FY25	Dec 31, 2024	3,249	+2.4%	Form 10-Q (FY2026Q2), filed 2026-01-23 ↗
Q1 FY25	Sep 30, 2024	3,147	+2.4%	Form 10-Q (FY2026Q1), filed 2025-10-24 ↗
Q4 FY24	Jun 30, 2024	2,674	+3.2%	Form 10-K, filed 2024-08-05 ↗
Q3 FY24	Mar 31, 2024	2,873	+1.6%	Form 10-Q (FY2025Q3), filed 2025-04-24 ↗
Q2 FY24	Dec 31, 2023	3,172	+4.0%	Form 10-Q (FY2025Q2), filed 2025-01-22 ↗
Q1 FY24	Sep 30, 2023	3,074	+11.5%	Form 10-Q (FY2025Q1), filed 2024-10-18 ↗
Q4 FY23	Jun 30, 2023	2,590	+3.2%	Form 10-K, filed 2024-08-05 ↗
Q3 FY23	Mar 31, 2023	2,828	+6.2%	Form 10-Q (FY2024Q3), filed 2024-04-19 ↗
Q2 FY23	Dec 31, 2022	3,051	+2.5%	Form 10-Q (FY2024Q2), filed 2024-01-23 ↗
Q1 FY23	Sep 30, 2022	2,757	+3.0%	Form 10-Q (FY2024Q1), filed 2023-10-18 ↗
Q4 FY22	Jun 30, 2022	2,510	+5.3%	Form 10-K, filed 2024-08-05 ↗
Q3 FY22	Mar 31, 2022	2,662	+13.0%	Form 10-Q (FY2023Q3), filed 2023-04-21 ↗
Q2 FY22	Dec 31, 2021	2,976	+8.4%	Form 10-Q (FY2023Q2), filed 2023-01-19 ↗
Q1 FY22	Sep 30, 2021	2,676	+8.3%	Form 10-Q (FY2023Q1), filed 2022-10-19 ↗
Q4 FY21	Jun 30, 2021	2,383	+18.3%	Form 10-K (FY2023), filed 2023-08-04 ↗
Q3 FY21	Mar 31, 2021	2,356	+4.2%	Form 10-Q (FY2022Q3), filed 2022-04-20 ↗
Q2 FY21	Dec 31, 2020	2,746	+8.5%	Form 10-Q (FY2022Q2), filed 2022-01-19 ↗
Q1 FY21	Sep 30, 2020	2,471	+11.3%	Form 10-Q (FY2022Q1), filed 2021-10-19 ↗
Q4 FY20	Jun 30, 2020	2,015	-1.1%	Form 10-K, filed 2020-08-06 ↗
Q3 FY20	Mar 31, 2020	2,262	+7.0%	Form 10-Q (FY2021Q3), filed 2021-04-20 ↗
Q2 FY20	Dec 31, 2019	2,530	+14.0%	Form 10-Q (FY2021Q2), filed 2021-01-20 ↗
Q1 FY20	Sep 30, 2019	2,221	+20.4%	Form 10-Q (FY2021Q1), filed 2020-10-20 ↗
Q4 FY19	Jun 30, 2019	2,038	+12.7%	Form 10-K, filed 2019-08-06 ↗
Q3 FY19	Mar 31, 2019	2,115	+9.4%	Form 10-Q (FY2020Q3), filed 2020-04-20 ↗
Q2 FY19	Dec 31, 2018	2,220	+0.4%	Form 10-Q (FY2020Q2), filed 2020-01-23 ↗
Q1 FY19	Sep 30, 2018	1,845	-3.0%	Form 10-Q (FY2020Q1), filed 2019-10-22 ↗
Q4 FY18	Jun 30, 2018	1,809	+4.0%	Form 10-K, filed 2018-08-07 ↗
Q3 FY18	Mar 31, 2018	1,934	+5.1%	Form 10-Q (FY2019Q3), filed 2019-04-23 ↗
Q2 FY18	Dec 31, 2017	2,212	+6.8%	Form 10-Q (FY2019Q2), filed 2019-01-23 ↗
Q1 FY18	Sep 30, 2017	1,902	+2.2%	Form 10-Q (FY2019Q1), filed 2018-10-19 ↗
Q4 FY17	Jun 30, 2017	1,739	-3.5%	Form 10-K, filed 2017-08-07 ↗
Q3 FY17	Mar 31, 2017	1,841	+3.8%	Form 10-Q (FY2018Q3), filed 2018-04-19 ↗
Q2 FY17	Dec 31, 2016	2,072	+4.8%	Form 10-Q (FY2018Q2), filed 2018-01-23 ↗
Q1 FY17	Sep 30, 2016	1,861	+3.6%	Form 10-Q (FY2018Q1), filed 2017-10-20 ↗
Q4 FY16	Jun 30, 2016	1,803	+5.7%	Form 10-K, filed 2016-08-09 ↗
Q3 FY16	Mar 31, 2016	1,773	-7.1%	Form 10-Q (FY2017Q3), filed 2017-04-26 ↗
Q2 FY16	Dec 31, 2015	1,978	-5.3%	Form 10-Q (FY2017Q2), filed 2017-01-20 ↗
Q1 FY16	Sep 30, 2015	1,796	-10.7%	Form 10-Q (FY2017Q1), filed 2016-10-25 ↗
Q4 FY15	Jun 30, 2015	1,705	-6.0%	Form 10-K, filed 2015-08-07 ↗
Q3 FY15	Mar 31, 2015	1,909	-1.5%	Form 10-Q (FY2016Q3), filed 2016-04-26 ↗
Q2 FY15	Dec 31, 2014	2,088	-3.0%	Form 10-Q (FY2016Q2), filed 2016-01-26 ↗
Q1 FY15	Sep 30, 2014	2,011	+6.2%	Form 10-Q, filed 2014-10-24 ↗
Q4 FY14	Jun 30, 2014	1,813	+273.0%	Form 10-Q, filed 2015-04-23 ↗
Q3 FY14	Mar 31, 2014	1,938	-19.5%	Form 10-Q, filed 2015-04-23 ↗
Q2 FY14	Dec 31, 2013	2,153	-12.8%	Form 10-Q, filed 2015-01-27 ↗
Q1 FY14	Sep 30, 2013	1,894	-18.4%	Form 10-Q, filed 2014-10-24 ↗
Q4 FY13	Jun 30, 2013	486	-121.5%	Form 10-K, filed 2014-08-08 ↗
Q3 FY13	Mar 31, 2013	2,406	-20.3%	Form 10-Q, filed 2014-04-23 ↗
Q2 FY13	Dec 31, 2012	2,470	-22.4%	Form 10-Q, filed 2014-01-24 ↗
Q1 FY13	Sep 30, 2012	2,322	-29.4%	Form 10-Q, filed 2013-10-25 ↗
Q4 FY12	Jun 30, 2012	-2,257	–	Form 10-K, filed 2014-08-08 ↗
Q3 FY12	Mar 31, 2012	3,018	+1.9%	Form 10-Q, filed 2012-04-27 ↗
Q2 FY12	Dec 31, 2011	3,183	+1.4%	Form 10-Q, filed 2012-01-27 ↗
Q1 FY12	Sep 30, 2011	3,291	+10.3%	Form 10-Q, filed 2011-10-27 ↗
Q3 FY11	Mar 31, 2011	2,962	+5.6%	Form 10-Q, filed 2011-04-29 ↗
Q2 FY11	Dec 31, 2010	3,138	–	Form 10-Q, filed 2012-01-27 ↗
Q1 FY11	Sep 30, 2010	2,984	–	Form 10-Q, filed 2011-10-27 ↗
Q3 FY10	Mar 31, 2010	2,805	–	Form 10-Q, filed 2011-04-29 ↗

Breakdown

What makes up health care — net sales

Cite this data

StockData. (2026). Procter & Gamble Health Care — Net Sales ($M), quarterly Q3 FY10–Q1 FY27 [Data set]. Compiled from Procter & Gamble SEC filings and investor materials. https://stockdatahq.com/stocks/pg/kpis/seg_econ_health_care_net_sales

See every metric in the Procter & Gamble KPI table. Data updated Oct 26, 2026.

Where these numbers come from

Parsed from the XBRL in Procter & Gamble's annual and quarterly filings with the SEC
Per-share figures adjusted for the 2-for-1 split on Jun 21, 2004
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Against peers

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is PG.

Compare: PG vs UL · PG vs CL · PG vs ECL · PG vs CHD · PG vs LLY

Revenue growth3.3% · median 7.6%

Gross margin50.2% · median 53.4%

Operating margin22.7% · median 16.7%

Net margin18.4% · median 12.2%

Company	Revenue	Growth
PG	$87.03B	+3.3%
LLY	$86.46B	+45.5%
CL	$21.28B	+5.9%
ECL	$17.37B	+9.3%
CHD	$6.25B	+1.7%
UL	–	–

Company

Next earnings (est.): Jan 21, 2027, before open
Exchange: NYSE
Industry: Soap, Detergents, Cleang Preparations, Perfumes, Cosmetics
Fiscal year ends: June 30
Employees: 104,000
Held by institutions: 70.3%
Auditor: Deloitte & Touche LLP
SEC CIK: 80424

Advertisement
300 × 250